Novel STAT3 Inhibitors to Treat Pediatric Brain Tumors

Technology #2017-235

Questions about this technology? Ask a Technology Manager

Download Printable PDF

David J. Daniels M.D., Ph.D.
Managed By
Jon H. Behringer
Patent Protection
US Patent Pending

Mayo Clinic has discovered that novel STAT3 inhibitors would potentially be a therapeutic treatment in pediatric tumor Diffuse Intrinsic Pontine Glioma (DIPG). Novel STAT3 inhibitors selectively killed tumor cells found in DIPG.